CHE — CHEMED CORP
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 19584 ·
Last close
$512.16
Market Cap
$6.69B
52W High
$556.27
52W Low
$364.23
ADV30
151,383
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 657,513,000 | 215,764,000 | 84,578,000 | 66,302,000 | 1,535,815,000 | 16,856,000 | 687,821,000 |
| Dec 2025 | 639,337,000 | 225,171,000 | 103,563,000 | 76,751,000 | 1,538,189,000 | 74,515,000 | 558,784,000 |
| Sep 2025 | 624,900,000 | 196,907,000 | 74,750,000 | 64,237,000 | 1,623,619,000 | 129,752,000 | 546,936,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$443,747,000
Investing CF
$-83,455,000
Financing CF
$-517,318,000
CapEx
$-66,631,000
Dividends Paid
$-32,543,000
Buybacks
$-588,317,000
EPS Diluted TTM
$19.91
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$3,013,504,000
Inventory
$7,208,000
Receivables
$215,479,000
ST Investments
—
EBIT TTM
$350,877,000
Pretax Income TTM
$348,944,000
Interest Exp TTM
$1,933,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,595,001,088
EBITDA
$416,918,016
Free Cash Flow
$307,859,488
Enterprise Value
$6,969,971,712
Total Cash
$40,222,000
Total Debt
$294,792,992
Shares Out
13,069,961
Trailing EPS
$19.86
Book Value
$63.81
ROE
27.1%
ROA
13.5%
Div Yield
0.54%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,529,978,000 | 341,155,000 | 265,238,000 | 1,538,189,000 | 558,784,000 | 979,405,000 | 388,272,000 |
| Dec 2024 | 2,431,287,000 | 366,939,000 | 301,999,000 | 1,668,575,000 | 549,582,000 | 1,118,993,000 | 417,497,000 |
| Dec 2023 | 2,264,417,000 | 342,830,000 | 272,509,000 | 1,668,095,000 | 560,219,000 | 1,107,876,000 | 330,299,000 |
| Dec 2022 | 2,134,963,000 | 347,187,000 | 249,624,000 | 1,442,012,000 | 643,297,000 | 798,715,000 | 309,886,000 |
TTM Snapshot
Revenues TTM
$2,235,936,000
NetIncome TTM
$288,581,000
OpCashFlow TTM
$0
Assets (Latest)
$1,538,189,000
Forward EPS
$27.52
Max Pain — expiry 2027-03-19
max pain strike: $600.00 · spot: $514.69 · call oi: 37 · put oi: 2,521Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | $6.62B | $29.42 | — |
| PACS | PACS Group, Inc. | $6.54B | $41.30 | — |
| GRAL | GRAIL, Inc. | $5.67B | $126.89 | — |
| RDNT | RadNet, Inc. | $5.57B | $70.79 | — |
| BLLN | BillionToOne, Inc. | $5.25B | $123.08 | — |
News headlines (Yahoo Finance, 1h cache)
Chemed (CHE) Stock May Be 26% Undervalued On Franchise Territory Deal
2026-09-26 13:10 · Yahoo
Roto-Rooter Buys Largest Franchisee Territory
2026-09-16 20:30 · Yahoo
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
2026-09-08 13:00 · Yahoo
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
2026-09-06 01:15 · Yahoo
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
2026-08-27 15:30 · Yahoo
OPCH or CHE: Which Is the Better Value Stock Right Now?
2026-08-25 15:40 · Yahoo
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
2026-08-14 15:33 · Yahoo
Chemed Corporation Declares Quarterly Dividend of 70 Cents
2026-08-06 15:57 · Yahoo
Chemed (CHE) Deepens Buybacks as Activist Pressure Mounts – What Does This Say About Strategy?
2026-07-30 21:07 · Yahoo
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
2026-07-30 16:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.